TVGN (Tevogen Bio Holdings) Total Equity: $-9.84 Mil (As of Mar. 2026)


TVGN Tevogen Bio Holdings Inc TVGN
10 GF Score
Price $5.69
! 4 Warning Signs
View Full Analysis

What is Tevogen Bio Holdings Total Equity?

Tevogen Bio Holdings TVGN +3.36% 10 Total Equity is $-9.84 Mil as of Mar. 2026. GuruFocus rates TVGN with a GF Score™ of 10/100. The stock has 4 warning signs investors should review.

Tevogen Bio Holdings's total equity for the quarter that ended in Mar. 2026 was $-9.84 Mil.

This is Residual interest, including minority interest, that remains in the assets of the enterprise after deducting its liabilities. Equity is increased by owners’ investments and by comprehensive income, and it is reduced by distributions to the owners.

Tevogen Bio Holdings Total Equity Historical Data

* Premium members only.

The historical data trend for Tevogen Bio Holdings's Total Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Tevogen Bio Holdings Total Equity Chart

Tevogen Bio Holdings Annual Data
Trend Dec21 Dec22 Dec23 Dec24 Dec25
Total Equity
-16.49 342.08 -94.43 -6.67 -8.24

Tevogen Bio Holdings Quarterly Data
Dec21 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Total Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -7.72 -9.49 -7.82 -8.24 -9.84
TVGN
10GF Score
Tevogen Bio Holdings Inc TVGN
Total Equity is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Tevogen Bio Holdings Total Equity Calculation

Total Equity and Total Liabilities are the two components for Total Assets.

Tevogen Bio Holdings's Total Equity for the fiscal year that ended in Dec. 2025 is calculated as

Total Equity=Total Assets(Q: Dec. 2025 )-Total Liabilities(Q: Dec. 2025 )
=4.383-12.618
=-8.24

Tevogen Bio Holdings's Total Equity for the quarter that ended in Mar. 2026 is calculated as

Total Equity=Total Assets(Q: Mar. 2026 )-Total Liabilities(Q: Mar. 2026 )
=4.921-14.763
=-9.84

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Equity →
What does a Total Equity of $-9.84 Mil mean?
Tevogen Bio Holdings (TVGN) has a Total Equity of $-9.84 Mil as of Mar. 2026. The total amount of equity as record on a company's balance sheet. View historical data for Tevogen Bio Holdings and its competitors.
Is Tevogen Bio Holdings' Total Equity too high?
Tevogen Bio Holdings' current Total Equity is $-9.84 Mil. Overall, Tevogen Bio Holdings has a GF Score™ of 10/100, reflecting its overall financial health beyond just this single metric.
How does Tevogen Bio Holdings' Total Equity compare to GRDX and DYAI?
Tevogen Bio Holdings' Total Equity of $-9.84 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Equity for a Biotechnology company?
A good Total Equity depends on the Biotechnology industry context. However, Total Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Equity mean?
A high Total Equity can signal that a stock is expensive relative to its fundamentals. The total amount of equity as record on a company's balance sheet. View historical data for Tevogen Bio Holdings and its competitors. Tevogen Bio Holdings's current Total Equity is $-9.84 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Tevogen Bio Holdings stock overvalued right now?
Tevogen Bio Holdings (TVGN) has a current Total Equity of $-9.84 Mil. The current Total Equity is $-9.84 Mil. Tevogen Bio Holdings' overall GF Score™ is 10/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Equity calculated?
Total Equity is calculated from a company's financial statements. For Tevogen Bio Holdings (TVGN), the current Total Equity is $-9.84 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Tevogen Bio Holdings Business Description

Address 15 Independence Boulevard, Suite 210, Warren, NJ, USA, 07059
Tevogen Bio Holdings Inc a clinical-stage specialty immunotherapy company harnessing CD8+ cytotoxic T lymphocytes (CD8+ CTLs or CTLs), to develop off-the-shelf, precision T cell therapies for the treatment of infectious diseases, cancers, and neurological disorders. The first clinical product of ExacTcell, TVGN 489, is initially being developed to fill a critical gap in COVID-19 therapeutics for the immunocompromised and the high-risk elderly, with potential applications in both treatment and prevention of chronic, lingering symptoms of the disease (Long COVID). Viruses, including COVID-19, hijack cellular machinery to transform infected cells into virus production plants.
10GF Score

Get the complete analysis for TVGN

Total Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$5.69
Price